SCHEMBL10067952

SCHEMBL10067952

CCNc1[nH]ncc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HCAR3 P49019 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.39
KDM4C Q9H3R0 4/20 0.37
KDM6B O15054 3/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
MAPT P10636 2/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30490177 0.84 ALDH1A1 (0.41) NPC1RAB9AGAAL3MBTL1HCAR3
SCHEMBL20689342 0.79 SMN1; SMN2 (0.46) NPC1RAB9AGAAL3MBTL1HCAR3
SCHEMBL9308438 0.76 TSHR (0.42) NPC1RAB9AGAAL3MBTL1ALDH1A1
SCHEMBL10037297 0.75 TSHR (0.39) NPC1RAB9AGAAL3MBTL1ALDH1A1
SCHEMBL9311809 0.73 KDM6B (0.39) NPC1RAB9AGAAL3MBTL1HCAR3
SCHEMBL14822490 0.72 HCAR2 (0.43) NPC1RAB9AGAAL3MBTL1ALDH1A1
SCHEMBL5515042 0.69 MAPT (0.38) GAAHCAR3ALDH1A1KMT2AKDM4C
SCHEMBL272809 0.69
SCHEMBL7740030 0.68 HCAR2 (0.45) NPC1RAB9AGAAL3MBTL1ALDH1A1
SCHEMBL21703593 0.67 HCAR3 (0.40) GAAL3MBTL1HCAR3ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077711-A1 Novel Ligands and Libraries of Ligands SUNESIS PHARMACEUTICALS, INC. (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077711-A1 Novel Ligands and Libraries of Ligands LSS, ABCG2, SELL NPC1 102/4885RAB9A 1673/4885GAA 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.